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Uniquely among the soluble lens-specific proteins, y-crystallin is capable of binding the strongly 
chromophoric aldehyde retinal. A role for y-crystallin in protecting lens components from toxic aldehydes 
resulting from membrane oxidation is proposed and a molecular model of the probable interaction site 
is presented. The sequence of a tetrapeptide at this site is identical to that of the retinal binding site of 
bacteriorhodopsin. 
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1. INTRODUCTION 
Oxidation is one of the major threats to the 
transparency of the ocular lens [ 11. Among its ef- 
fects is the release of toxic molecules including 
aliphatic aldehydes from lens membranes [2]. It is 
possible that such oxidation products are involved 
in the processes of cataractogenesis and aging, in- 
cluding protein aggregation [3] and the accumula- 
tion of unusual chromophores [l]. The tissue- 
specific structural proteins LY-, & and y-crystallins 
are the major molecular components of mam- 
malian lenses [3]. These proteins are extremely 
stable, surviving without turnover for years in the 
ennucleated lens fibre cells. We have examined the 
interaction of lens proteins with aldehydes and 
have found that only one fraction, y-crystallin, 
binds the model compound retinal. 
retinal were mixed in cuvettes and difference spec- 
tra measured against retinal in a Cary 15 spec- 
trophotometer. For both all-truns and 11-cis 
stereoisomers of retinal there was no reaction 
observed with LY- or ,&crystallins at pH 7. 
However, y-11 and y-111 crystallins, which have 
closely related amino-acid sequences [6,7], reacted 
with both stereoisomers identically. Difference ab- 
sorption peaks were observed around 445 nm 
(fig.la) with troughs at 380 nm corresponding to 
the absorption maximum of free retinal. The ab- 
sorption at 445 nm was abolished within 20 min by 
addition of the reducing agent sodium cyanoboro- 
hydride [8] to both cuvettes. After extraction of 
free retinal with hexane, direct spectroscopy of the 
protein sample showed a small absorption at 320 
nm (fig. lb). 
2. METHODS AND RESULTS 
c&rystallin, fi-crystallin and y-11 and y-111 
crystallins were extracted from calf lenses [4, 51. 
As an analogue of the aliphatic aldehydes that are 
oxidatively liberated from membrane, the strong 
chromophore retinal (vitamin A aldehyde) was us- 
ed. Equimolar quantities of protein subunits and 
These results are characteristic of the formation 
and reduction of a protonates Schiff’s base. At pH 
6 and pH 8 there was no observable reaction. 
The experiments were repeated with two other 
strongly chromophoric aldehydes pyrixodal 
phosphate and o-phthalaldehyde. These cyclic 
molecules gave no observable reaction, suggesting 
a degree of shape specificity in the binding of 
aldehydes to the protein. 
The nature of the Schiff’s base binding site was 
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Fig. 1. Spectroscopy of the reaction between y-11 and 
retinal. (a) Solid line shows the difference spectrum of y- 
II (5 x 10T5 M) + all-trans retinal (5 x lo-‘M) against 
all-trans retinal (5 x 10e5 M). Solutions were in 60 mM 
phosphate buffer (pH 7.1). Retinal (1 mM in ethanol) 
was mixed with buffer and spectra recorded at once. 
Dotted line shows the difference spectrum of the same 
sample 20 min after addition of sodium cyanoborohy- 
dride (lo-’ M) to both cuvettes. The trough represents 
free retinal which has absorption in the protein region, 
hence the apparent decline in the absorption of the pro- 
tein. Identical results were obtained with II-cis retinal 
and with calf y-111. (b) Solid line shows the spectrum of 
retinyl-y-II extracted 3 times with hexane to remove free 
retinal. Dotted line shows the spectrum of native y-11. 
further investigated using y-11 crystallin for which 
a complete amino acid sequence and three- 
dimensional structure are known [9- Ill. The reac- 
tion with y-11 was repeated using tritium-labelled 
all-trans retinal (a gift from the National Cancer 
Institute, manufactured by SRI International) 
substituting sodium borohydride as reducing 
agent. In SDS-urea-20% PAGE [12] label com- 
igrated with the y-11 protein band at 20 kDa under 
these dissociating conditions. Total hydrolysis of 
the [3H]retinyl-y-II using 2.5 M NaOH yielded a 
ninhydrin-positive, labelled component with the 
same mobility as retinyl-lysine in thin-layer 
chromatography on silica gel H using a butan- 
ol-acetic acid-water system [13]. Lysine has been 
shown to be the active residue for retinal binding 
in both bacteriorhodopsin [141 and rhodopsin [ 13 ]
and it is also responsible for pyridoxal phosphate 
binding in numerous enzymes [ 151. y-11 crystallin 
has only two lysine residues, Lys 2 and Lys 154. 
The sequence of calf y-11 shows that. Lys 2 is 
contained in a cyanogen bromide fragment of at 
least 5.1 kDa while Lys 154 is in a much smaller 
peptide of only 1 .l kDa (1.4 kDa if modified with 
retinal). 
[3H]Retinyl-y-II was subjected to CNBr cleav- 
age [16] and the peptides were separated by 
SDS-urea-PAGE [ 121 a system capable of resolv- 
ing peptides down to a size of 3 kDa. A major pep- 
tide band was apparent at about 5 kDa with other 
bands at lower &values. Autoradiography show- 
ed that there was no label associated with the 
5-kDa band. However, a species of 3 kDa but 
migrating more slowly than free retinal was strong- 
ly labelled. These results suggest hat retinal binds 
to Lys 154. 
3. DISCUSSION 
One role of y-crystallin may be to buffer the lens 
against oxidation by the safe accumulation of in- 
tramolecular disulphide bonds [lO,ll]. The results 
presented here further suggest hat the protein is 
capable of another protective role in scavenging 
linear aldehydes, similar to retinal, released from 
damaged membranes. Modified and unmodified 
Schiff’s bases resulting from these reactions would 
contribute to the coloured and fluorescent moieties 
observed in aging and cataractous lenses. Conse- 
quent upon membrane breakdown, or the genera- 
tion of aldehydes from other sources by free 
radicals, y-crystallin could bind the aldehydes, 
protecting glutathione, enzymes and other lens 
components [ 171. Under normal conditions the 
labile aIdehyde binding sites would probably be 
regenerated and the aldehydes reduced. 
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However, in more extreme circumstances y- 
crystallin bound to aldehyde could become involv- 
Fig. 2. A model to illustrate the proposed retinal binding 
site. Protein coordinates for calf r-11 crystallin are from 
the 1.9. A resolution X-ray analysis after least-squares 
refinement [ 10,111. (a) The a-carbon backbone of y-11 
showing the position of the proposed binding site. (b) A 
more detailed view of the site. The side chain of Lys 154 
has been moved in model-building using the interactive 
program FRODO [25]. Retinal (heavy line) is shown in 
the 11-k conformation [26]. The Ala-Lys-Val-Gly 
tetrapeptide is shown in dashed lines. The nearby 
hydrophobic residues Mettz,, Pro128 are shown dotted. 
It is hoped that crystallographic analysis of retinyl-y-II 
will be possible, allowing detailed visualization of the 
binding site. 
ed in cataract formation. Electrophilic addition of 
sulphydryl and other groups to the Schiff’s base 
could lead to protein cross-linking [3], membrane 
anchoring of y-crystallin [ 181 and other pheno- 
mena observed in cataract. Aldehyde binding to 
lens protein in cataract has been described [191; the 
dialdehyde malondialdehyde, which has been 
detected in cataractous lenses, may react with 
crystallins leading to precipitation [20]. In the 
crystallographic analysis of y-11 crystallin 
glutaraldehyde was used to crosslink crystals and 
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this produced a yellow colour (unpublished), 
reminiscent of the yellowing of lenses with age. 
Finally, it is interesting to note that Lysr54 is 
contained in a tetrapeptide Ala-Lys-Val-Gly 
identical to the retinal binding site in 
bacteriorhodopsin [21]. y-11 has only 2 alanine and 
2 lysine residues [6] so the homology has added 
significance. There does not seem to be any ob- 
vious reason why this sequence in itself should con- 
tribute to non-enzyme mediated retinal binding. In 
bovine and ovine opsins the ‘binding sequences’ 
differ, although both have Ala-Lys followed by 
two small residues [22-241. It would seem more 
likely that tertiary structure is responsible for the 
formation of a binding site. 
Starting with the known structure of Y-11, [9-l l] 
computer graphics model ,building was used to in- 
vestigate the proposed Lysrs4 aldehyde binding 
site. Close by are two solvent-exposed, non-polar 
residues Met127 and Prorzs. These could form a 
hydrophobic patch, stabilizing retinal binding by 
the elimination of entropically unfavourable con- 
tacts with water. The close proximity of the lysyl 
amino group and aldehyde would then favour 
reaction. Fig. 2 shows a model of this region of y- 
II with retinal bound, demonstrating the disposi- 
tion of residues and the relative size of the ligand. 
It is unlikely that retinal itself ever reaches high 
levels in the lens, except in cases where degenera- 
tion of the retina occurs. Shorter aliphatic 
aldehydes are the likely physiological ligands for 
the site. 
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